Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
Top Cited Papers
Open Access
- 8 April 2021
- journal article
- research article
- Published by Elsevier BV in Kidney International
- Vol. 99 (6), 1280-1295
- https://doi.org/10.1016/j.kint.2021.03.020
Abstract
No abstract availableThis publication has 200 references indexed in Scilit:
- Effect of ferric carboxymaltose on serum phosphate and C-terminal FGF23 levels in non-dialysis chronic kidney disease patients: post-hoc analysis of a prospective studyBMC Nephrology, 2013
- Ferritin levels and risk of type 2 diabetes mellitus: an updated systematic review and meta‐analysis of prospective evidenceDiabetes/Metabolism Research and Reviews, 2013
- Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesisJCI Insight, 2012
- FGF23 induces left ventricular hypertrophyJCI Insight, 2011
- Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney DiseaseJAMA, 2011
- Do two intravenous iron sucrose preparations have the same efficacy?Nephrology Dialysis Transplantation, 2011
- Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: Another form of FGF23-related hypophosphatemiaBone, 2009
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing HemodialysisThe New England Journal of Medicine, 2008
- Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase PathwayMolecular Cell, 2008
- Interleukin-6 induces hepcidin expression through STAT3Blood, 2006